Hanall Biopharma Co., Ltd. 009420
KRX · South Korea · Health Technology
KRW 48,500.00+4,400.00 (+9.98%)
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-01-21 | — | — | — | KRW 37.55B | -7.1% | -3.2%KRW 49,500.00→KRW 47,900.00 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.